Navigation Links
Aratana Therapeutics to Host Pet Therapeutics Primer and Product Update Event
Date:8/29/2013

#160;

Dr. Ernst Heinen, Aratana's Head of Drug Development and Evaluation, will provide an in-depth development update for each of Aratana's current product candidates, each of which is being developed concurrently for both cats and dogs.  These include AT-001, the Company's EP4 antagonist for the treatment of pain; AT-002, its ghrelin agonist for treating inappetence; and AT-003, Aratana's liposomal bupivacaine injection for treating post-operative pain.

There will be an opportunity for Q&A after each session, during which Dr. Marie-Paul Lachaud, Aratana's Head of Drug Development in Europe; Tammy Newbold, Aratana's Vice President of Chemistry, Manufacturing and Controls; and Don Stitzenberg, Aratana's Vice President of Manufacturing, will also be available.

About Aratana Therapeutics
Aratana Therapeutics is a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, or pet therapeutics. Aratana believes that it can leverage the investment in the human biopharmaceutical industry to bring therapeutics to pets in a capital and time efficient manner. Aratana's strategy is to in-license proprietary compounds from human biopharmaceutical companies and to develop these product candidates into therapeutics specifically for use in pets. Aratana believes the development and commercialization of these therapeutics will permit veterinarians and pet owners to manage pets' medical needs safely and effectively, resulting in longer and improved quality of life for pets.  For more information, please visit www.aratana.com.

Contacts:
Tiberend Strategic Advisors, Inc.

Joshua Drumm, Ph.D. (investors)

SOURCE Aratana Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Aratana Therapeutics Reports Second Quarter 2013 Financial Results
2. Aratana Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering
3. Aratana Therapeutics to Present at Two Upcoming Healthcare Conferences
4. Aratana Closes $12 Million Series C Financing to Fund Pipeline Expansion
5. Aratana Therapeutics Appoints Erick Lucera Vice President of Corporate Development
6. Aratana to Present at Bank of America Merrill Lynch Animal Health Summit
7. Aratana to Participate in Leerink Swanns November Management Access Days
8. Carolus Therapeutics and The Alpha-1 Project Collaborate to Validate CT-2009 Target as Important in Human Disease
9. Echo Therapeutics Announces Management Changes
10. aTyr Pharma Awarded Two Patents from USPTO to Support Development of New Therapeutics Based on Physiocrine Biology
11. aTyr Pharma Expands Executive Leadership Team to Support Development of New Therapeutics Based on Physiocrine Biology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... WASHINGTON , Feb. 26, 2015  Mail-service ... consumers, employers and government health plans ... research released by the Pharmaceutical Care Management Association ... specialty drugs offers one of the easiest ways ... CEO Mark Merritt . "Policymakers should resist ...
(Date:2/26/2015)... 2015 Every year many millions of donations ... disease.  Nevertheless, year after year doctors and the medical ... first test to determine the status of heart health ... not, even though that technology is over 100 years ... doctors know, (while most patients do not know) that ...
(Date:2/26/2015)... DUBLIN , Feb. 26, 2015 Research and ... addition of the "Radiation Therapy Equipment - Global ... This report analyzes the worldwide markets for ... Product Segments: Linear Accelerator, Treatment Planning Systems, and Radiation ... the US, Canada , ...
Breaking Medicine Technology:PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2National Heart Health Month In February 2Radiation Therapy Equipment - Global Strategic Business Report 2015-2020: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator 2
(Date:2/27/2015)... 27, 2015 Today, February 27th, is "Shine ... , along with LXR Organics and Living ... Campaign to raise awareness and promote prevention, rescue and restoration ... by the END IT Coalition, slavery is the 2nd largest ... exists in 167 countries around the world. Slavery includes bonded ...
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 Pipette.com ... Vortex-Genie® 2 , price is only valid until the ... lab technicians looking for a vortex mixer that allows ... Industries was founded in 1954 and is headquartered in ... mixers & shakers, as well as other rockers, incubators, ...
(Date:2/27/2015)... February 27, 2015 The federal court ... that allege use of the statin medication can increase ... issued a new order pertaining discovery in the cases ... Liebhard LLP comments. The Order, which was issued in ... February 25th, directs the parties to schedule certain witness ...
(Date:2/27/2015)... Legislation passed today by the ... provision to help prevent inappropriate prescriptions in Medicare ... Protecting the Integrity of Medicare Act (PIMA), introduced ... Brady (R-TX) and Ranking Member Jim McDermott (D-WA), ... abuse epidemic and implement the right policies, said ...
(Date:2/27/2015)... Victorian Hotel recently celebrated Valentine’s Day in ... to spend the auspicious day together. This Vancouver hotel ... on Valentine’s Day with a sweet overnight package, including ... luxurious rooms. , The hotel started its Valentine’s ... mouthwatering 3 course meal at Café 335. This is ...
Breaking Medicine News(10 mins):Health News:KAJ Brothers Join the Campaign to 'End It - Shine A Light On Slavery' 2Health News:Pipette.com Announces Limited Time Offer of 24% Off List Price on the Vortex-Genie 2 2Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 2Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 3Health News:PCMA Statement on the ‘Protecting the Integrity of Medicare Act’ 2Health News:Victorian Hotel Celebrated Valentine’s Day in 2015 With Unique Overnight Deal 2
... launches $20,000 Nationwide Scholarship, Competition with Celebrity Spokesperson Megyn Price of ... ... NEW YORK, May 9 The Tea Council of the USA,Inc. ... scholarship competition awarding one creative student $20,000,towards their education, in an ...
... Daisy Fuentes in honoring Emilio and Gloria Estefan at the event to ... ... Luis Fonsi, Jeremias, and Valeria Gastaldi, MIAMI, May 9 St. ... its sixth annual FedEx/St. Jude Angels & Stars Gala on Saturday,May 17, ...
... 9 Oceana, an international,ocean conservation group based in ... many years. Consuming big fish high on,the food chain ... mercury, a heavy,metal that can cause neurological and other ... celebrity spokes-Mom Amber Valletta,offers a few tips for keeping ...
... 9 VNUS(R) Medical,Technologies, Inc. today announced that the ... second continuation patent application related to,the patents in the ... This comes on the heels of the Patent Office,s,decision ... also filed,as a continuation of one of the patents ...
... of infected patients in U.K., researchers say , , ... Steno, one the most recent "superbugs" to claim lives, ... resist antibiotics and other drugs, according to soon-to-be-published findings. ... thrives in moist environments, such as around taps and ...
... Remain Stable or Improve in 86% at Six Months, ... NDQ), a developer of real-time imaging and image guidance ... independent data was,presented at the recent Association for Research ... April 26 - May,1, 2008. Data from two of ...
Cached Medicine News:Health News:Drink Tea. Win $20,000. Experience the 'Calm-A-Sutra of Tea' 2Health News:Drink Tea. Win $20,000. Experience the 'Calm-A-Sutra of Tea' 3Health News:Miami Rolls Out the Red Carpet for Latin Star Studded FedEx/St. Jude Gala 2Health News:Miami Rolls Out the Red Carpet for Latin Star Studded FedEx/St. Jude Gala 3Health News:Amber Valletta on Preventing Mercury Exposure 2Health News:Amber Valletta on Preventing Mercury Exposure 3Health News:U.S. Patent Office Allows Another Significant VNUS Patent 2Health News:U.S. Patent Office Allows Another Significant VNUS Patent 3Health News:Steno 'Superbug' Genome Shows Extreme Drug Resistance 2Health News:Novadaq's OPTTX System Data Presented at ARVO 2Health News:Novadaq's OPTTX System Data Presented at ARVO 3Health News:Novadaq's OPTTX System Data Presented at ARVO 4
... CMC joint is the most common site for ... the CMC joint without restricting the wrist or ... persons who need to control or reduce subluxation ... perform work and leisure activities without pain. Also ...
... This is an excellent choice to treat ... MCP joint, basal joint arthritis, advanced carpal ... the thumb and wrist. Distal palmar ... flexion and full finger dexterity. Constructed ...
... CTi Wrist OTS is an off-the-shelf wrist orthotic designed ... of 3 pre-set ranges-of-motion (20°,35° and 50°). , ... sprains with TFCC tear-triangular fibrocartilage complex , ... nonunion , Partial tendon rupture , ...
... CTi Wrist Static is a solid, one-piece custom wrist ... stable, neutral position. , ,Indications: , Wrist ... fibrocartilage complex , Coles fracture - distal ... Partial tendon rupture , ORIF - Open ...
Medicine Products: